AnaptysBio, Inc. ANAB

Set alert

Price alert · ANAB

All alert types
47.66 USD +0.75 +1.61%

As of Nov 3, 2:21 PM ET

Bid
47.68 × 3
Ask
47.75 × 2
47.36 Day range 48.35
20.18 52-week range 72.36
YTD
+47.47%
1 year
+98.35%
Open
47.36
Prev close
46.91
Mkt cap
1.43B
Vol
97.58K
Avg vol
484.03K
EPS
-0.96
P/E
0.00
Div yield
0.00%
More statistics
Low
47.36
High
48.35
Forward P/E
10.34
Beta
0.37
Short ratio
9.41
Inst. own
105.65%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
51.76
200-d avg
50.40
1y target
87.25

1D chart

Chart tools
Interval

Signals (25)
NameTimeAgo
MACD: Buy Signal11:12 AM1 day ago
RSI: Oversold11:06 AM1 day ago
RSI: Oversold10:58 AM1 day ago
SMA: Bearish10:56 AM1 day ago
SMA: Bullish10:55 AM1 day ago
MACD: Sell Signal10:55 AM1 day ago
SMA: Bearish10:52 AM1 day ago
SMA: Bearish10:52 AM1 day ago
SMA: Bullish10:45 AM1 day ago
SMA: Bullish10:45 AM1 day ago
MACD: Buy Signal10:44 AM1 day ago
MACD: Sell Signal10:31 AM1 day ago
SMA: Bearish10:30 AM1 day ago
SMA: Bearish10:30 AM1 day ago
MACD: Buy Signal10:26 AM1 day ago
SMA: Bullish10:25 AM1 day ago
SMA: Bullish10:25 AM1 day ago
RSI: Oversold10:19 AM1 day ago
SMA: Bearish10:15 AM1 day ago
MACD: Sell Signal10:15 AM1 day ago

Newest 20 of 25.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 87.25 +83.1% upside
Target (low)
60.00
Target (mean)
87.25
Target (high)
140.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ANAB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.530880.00 – 1.290.52+2.1%33.46M-56.2%3
Next quarter1.060.10 – 2.011.58-32.7%52.38M-51.6%3
Current year4.202.49 – 7.06-0.46+1012.5%101.12M-56.9%4
Next year4.542.42 – 8.774.20+8.1%171.31M+69.4%5

Upgrades and downgrades

The latest rating changes

ANAB analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026JP MorganMaintainedOverweightOverweight
Sep 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2026Leerink PartnersMaintainedOutperformOutperform
Aug 25, 2026TD CowenMaintainedBuyBuy
Aug 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 13, 2026UBSMaintainedBuyBuy
May 13, 2026BarclaysMaintainedOverweightOverweight
May 4, 2026Piper SandlerMaintainedOverweightOverweight
Apr 28, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 22, 2026BarclaysMaintainedOverweightOverweight
Apr 21, 2026UBSMaintainedBuyBuy
Mar 31, 2026Piper SandlerMaintainedOverweightOverweight
Mar 30, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 17, 2026UBSMaintainedBuyBuy
Mar 12, 2026WedbushMaintainedOutperformOutperform
Mar 9, 2026Truist SecuritiesMaintainedHoldHold
Mar 5, 2026StifelMaintainedBuyBuy
Mar 4, 2026BarclaysMaintainedOverweightOverweight
Mar 4, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 20, 2026BarclaysMaintainedOverweightOverweight
Dec 17, 2025BarclaysMaintainedOverweightOverweight
Dec 11, 2025StifelMaintainedBuyBuy
Nov 24, 2025WedbushReiteratedOutperformOutperform
Nov 24, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 11, 2025BarclaysMaintainedOverweightOverweight
Nov 11, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 10, 2025Truist SecuritiesMaintainedHoldHold
Nov 5, 2025GuggenheimMaintainedBuyBuy
Nov 5, 2025Wells FargoMaintainedOverweightOverweight
Oct 29, 2025StifelMaintainedBuyBuy